JJ
Johnson & Johnson Portfolio holdings
AUM
$652M
1-Year Est. Return
198.07%
This Fund
S&P 500
1 Year Est. Return
+198.07%
AUM
$652M
AUM Growth
+$97.3M
(+18%)
Holding
17
Top Buys
No buys this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Protagonist Therapeutics
PTGX
$6B
| $258M | 39.57% |
2,449,183
|
|
||
|
NBTX
2
Nanobiotix
NBTX
$1.86B
| $174M | 26.61% |
5,623,816
|
|
||
3
MeiraGTx Holdings
MGTX
$856M
| $57.5M | 8.82% |
6,641,064
|
|
||
|
RAPP
4
Rapport Therapeutics
RAPP
$1.67B
| $55.8M | 8.56% |
1,784,517
|
|
||
5
CVRx
CVRX
$144M
| $38.1M | 5.84% |
4,024,861
|
|
||
|
CTNM
6
Contineum Therapeutics
CTNM
$463M
| $25.8M | 3.96% |
1,979,173
|
|
||
7
Legend Biotech
LEGN
$6.74B
| $14.7M | 2.26% |
814,586
|
|
||
8
Xencor
XNCR
$831M
| $9.02M | 1.38% |
748,062
|
|
||
9
Procept Biorobotics
PRCT
$1.52B
| $8.95M | 1.37% |
357,939
|
|
||
10
Fate Therapeutics
FATE
$300M
| $4.05M | 0.62% |
3,379,064
|
|
||
11
Neumora Therapeutics
NMRA
$324M
| $3.61M | 0.55% |
1,849,445
|
|
||
12
Rallybio
RLYB
$94.1M
| $1.37M | 0.21% |
152,901
-301,644
|
|
||
13
Vor Biopharma
VOR
$740M
| $959K | 0.15% |
53,732
|
|
||
14
Standard BioTools
LAB
$453M
| $287K | 0.04% |
311,967
|
|
||
15
Nano X Imaging
NNOX
$134M
| $190K | 0.03% |
83,554
-75,298
|
|
||
16
Adicet Bio
ACET
$75.8M
| $155K | 0.02% |
22,779
|
|
||
17
Lyell Immunopharma
LYEL
$347M
| – | – |
-54,887
|
|